Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Total Current Liabilities (2016 - 2025)

Palisade Bio (PALI) has disclosed Total Current Liabilities for 16 consecutive years, with $3.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Current Liabilities rose 29.73% to $3.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $3.5 million, a 29.73% increase, with the full-year FY2024 number at $3.2 million, up 25.14% from a year prior.
  • Total Current Liabilities was $3.5 million for Q3 2025 at Palisade Bio, down from $4.0 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $4.0 million in Q2 2025 to a low of $1.0 million in Q1 2021.
  • A 5-year average of $2.7 million and a median of $2.8 million in 2024 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: surged 469.55% in 2021, then decreased 29.45% in 2023.
  • Palisade Bio's Total Current Liabilities stood at $2.9 million in 2021, then rose by 3.15% to $3.0 million in 2022, then dropped by 14.14% to $2.6 million in 2023, then increased by 25.14% to $3.2 million in 2024, then rose by 7.48% to $3.5 million in 2025.
  • Per Business Quant, the three most recent readings for PALI's Total Current Liabilities are $3.5 million (Q3 2025), $4.0 million (Q2 2025), and $2.8 million (Q1 2025).